CRISPR-X
LIVE

Serial Number

99555280

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Dec 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CRISPR-X Trademark

Serial Number: 99555280

CRISPR-X is a trademark filed by CRISPR Therapeutics AG on December 18, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

December 18, 2025

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development in the field of gene editing, delivery and formulation; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 18, 2025 MAFR
NEW APPLICATION ENTERED
Dec 18, 2025 NWAP